[en] The complete H-1- and C-13-NMR assignments of the major Cannabis constituents, Delta(9)-tetrahydrocannabinol, tetrahydrocannabinolic acid, A-tetrahydrocannabinol, cannabigerol, cannabinol, cannabidiol, cannabidiolic acid, cannflavin A and cannflavin B have been determined on the basis of one- and two-dimensional NMR spectra including H-1- and (13)-NMR, H-1-H-1-COSY, HMQC and HMBC. The substitution of carboxylic acid on the cannabinoid nucleus (as in tetrahydrocannabinolic acid and cannabidiolic acid) has a large effect on the chemical shift of H-1" of the C5 side chain and 2'-OH. It was also observed that carboxylic acid substitution reduces intermolecular hydrogen bonding resulting in a sharpening of the H-5' signal in cannabinolic acid in deuterated chloroform. The additional aromaticity of cannabinol causes the two angular methyl groups (H-8 and H-9) to show identical H-1-NMR shifts, which indicates that the two aromatic rings are in one plane in contrast to the other cannabinoids. For the cannabiflavonoids, the unambiguous assignments of C-3' and C-4' of cannflavin A and B were determined by HMBC spectra. Copyright (C) 2004 John Wiley Sons, Ltd.
Abdoud RT, Sanders HD. 1976. Effect of oral administration of Δ9-THC on airways mechanics in normal and asthmatic subjects. Chest 70: 480-485.
Agrawal PK. 1989. Carbon 13-NMR of Flavonoids. Elsevier: Amsterdam; 136.
Archer RA, Johnson DW. 1977. Carbon-13 nuclear magnetic resonance spectroscopy of naturally occurring substances. 47. Cannabinoid compounds. J Org Chem 42: 490-495.
Barrett ML, Scutt AM, Evans FJ. 1986. Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 42: 452-453.
Crombie L, Crombie WM, Jamieson SV, Palmer CJ. 1988. Acid-catalysed terpenylations of olivetol in the synthesis of cannabinoids. J Chem Soc Perkin Transl 1243-1250.
Evans DA, Shaughnessy EA, Barnes DM. 1997. Cationic bis(oxazoline)Cu(II) Lewis acid catalysts. Application to the asymmetric synthesis of ent-Δ1-tetrahydrocannabinol. Tetrahedron Lett 38 3193-3194.
Fellermeier M, Eisenreich W, Bacher A, Zenk MH.2001. Biosynthesis of cannabinoids. Eur J Biochem 268: 1596-1604.
Formukong EA, Evans AT, Evans FJ. 1989. The medical uses of cannabis and its constituents. Phytother Res 3: 219-235.
Helper RS, Frank IM. 1971. Marijuana smoking and intraocular pressure. JAMA 217: 1392.
Iversen L, Chapman V. 2002. Cannabinoids: a real prospect for pain relief. Curr Opin Pharmac 2: 50-55.
Karplus M. 1959. Contact electron-spin coupling of nuclear magnetic moments. J Chem Phys 30: 11-15.
Mechoulam R, McCallum K, Burstein S. 1976. Recent advances in the chemistry and biochemistry of cannabis. Chem Rev 76: 75-112.
Razdan RK, Dalzell HC, Handrick GR. 1974. Hashish. A simple one-step synthesis of (-)-D1-tetrahydrocannabinol (THC) from p-mentha-2,8-dien-1-ol and olivetol. J Am Chem Soc 96: 5860-5865.
Russo E. 1998. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain 76: 3-8.
Turner CE, Elsohly MA, Boeren G. 1980. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 43: 169-234.